Agencies | Governor
Virginia Regulatory Town Hall
Health and Human Resources
Department of Health Professions
Board of Pharmacy
Mandate 818

Mandate Information
Mandate Title:
Naloxone; dispensing for use in opioid overdose reversal, etc.
Purpose of legislation
Allows a person who is authorized by the Department of Behavioral Health and Developmental Services to train individuals on the administration of naloxone for use in opioid overdose reversal and who is acting on behalf of an organization that provides services to individuals at risk of experiencing opioid overdose or training in the administration of naloxone for overdose reversal and that has obtained a controlled substances registration from the Board of Pharmacy pursuant to ยง 54.1-3423 to dispense naloxone to a person who has completed a training program on the administration of naloxone for opioid overdose reversal, provided that such dispensing is (i) pursuant to a standing order issued by a prescriber, (ii) in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, and (iii) without charge or compensation. The bill also provides that dispensing may occur at a site other than that of the controlled substance registration, provided that the entity possessing the controlled substance registration maintains records in accordance with regulations of the Board of Pharmacy. The bill further provides that a person who dispenses naloxone shall not be liable for civil damages of ordinary negligence for acts or omissions resulting from the rendering of such treatment if he acts in good faith and that a person to whom naloxone has been dispensed pursuant to the provisions of the bill may possess naloxone and may administer naloxone to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose. The bill contains an emergency clause.
Legislation mandating a change Chap 55 (2017)
Chap 168 (2017)
VAC chapters to be amended
18 vac 110 - 20 : Regulations Governing the Practice of Pharmacy
Associated Regulatory Actions
Action 4789: Controlled substances registration for naloxone and teleprescribing
Latest Stage: Final
spacer spacer
Back to Mandates